Abstract:AbstractBackgroundNa+‐Ca2+ exchanger isoform‐3 (NCX3) take‐parts in the aberrant Ca2+‐influx seen during neuronal excitotoxicity. However, the NCX3‐Aβ1‐42‐associated cytotoxicity and whether renovation of the aggregated Aβ1‐42‐induced NCX3 downregulation prevents or delays the onset of Alzheimer’s disease (AD) and AD‐related pathology remain unclear. Withania somnifera (W. somnifera), an indigenous traditional medicinal plant, has a long history of uses in preventing aging‐related neurological‐health impairments. However, this plant’s roots extract therapeutic value in neurodegenerative diseases, such as AD, albeit far less well studied.MethodsMicroscopic fluorescence and haemocytometer cell viability counting were performed to examine contributions of NCX3 against Aβ1‐42‐induced cytotoxicity in BHK‐cells. Authenticated W. somnifera‐dried‐roots were powdered, and the powder’s methanolic extract was used for phytochemical screening of the roots‐bioactive constituents and the 5×FAD mice gavage treatments from postnatal day 30 (P30) to P60 while maintaining their daily bodyweight records. After treatments, in vivo‐cognitional studies and then neurochemical‐examinations of the NCX3 immunoblot expression level, a sandwich ELISA and microscopy of Aβ plaque deposition, and antioxidant activity assays were performed in the AD‐associated brain regions at the mice age of 4 months.ResultsThe cell‐based studies revealed positive roles of NCX3 in the resistance against Aβ1‐42 exposure toxicological damages. Phytochemical screening of the extract attested presence of antioxidants as major bioactive constituents of the roots. The mice recorded bodyweights during treatments statistical‐analysis evidenced that the extract has no potential toxicity. The cognitional studies data indicates that the treatment group mice showed significant improvements than vehicles (p<0.01). Interestingly, subsequent studies in the mice’s cortex‐ and hippocampus‐homogenates showed that the W. somnifera prevents NCX3 suppression, significantly reduces Aβ1‐42 expression, and normalizes oxidative stress. Moreover, confocal microscope immunoreactive studies indicated reduced depositions and distributions of Aβ plaques in the treatment group AD‐associated brain tissues.ConclusionThese findings suggest the relevance of NCX3 against effects of Aβ1‐42‐associated cytotoxicity and that the W. somnifera antioxidant constituent’s bioactivity with no indications of toxicity, operating against Aβ‐induced NCX3 downregulation, may have a therapeutic role for augmenting NCX3 physiological properties in the maintenance of ionic Ca2+ homeostasis and ameliorates cognition in the 5×FAD mouse‐model, and therefore, might be valuable in AD‐pharmacological medicine.

Notopterygium incisum extract (NRE) rescues cognitive deficits in APP/PS1 Alzhneimer's disease mice by attenuating amyloid-beta, tau, and neuroinflammation pathology

Notopterygium incisum roots extract (NRE) alleviates neuroinflammation pathology in Alzheimer's disease through TLR4-NF-κB pathway

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer's disease

Naringenin Ameliorates Amyloid-Β Pathology and Neuroinflammation in Alzheimer’s Disease

A New Chiral Pyrrolyl Alpha-Nitronyl Nitroxide Radical Attenuates Beta-Amyloid Deposition And Rescues Memory Deficits In A Mouse Model Of Alzheimer Disease

A New Chiral Pyrrolyl α-Nitronyl Nitroxide Radical Attenuates β-Amyloid Deposition and Rescues Memory Deficits in a Mouse Model of Alzheimer Disease

Electroacupuncture Attenuates Reference Memory Impairment Associated with Astrocytic NDRG2 Suppression in APP/PS1 Transgenic Mice.

NeuroProtect, a Candidate Formula From Traditional Chinese Medicine, Attenuates Amyloid-β and Restores Synaptic Structures in APP/PS1 Transgenic Mice

An Exploration in Caenorhabditis elegans Models

Angiotensin-(1–7) Analogue AVE0991 Modulates Astrocyte-Mediated Neuroinflammation via lncRNA SNHG14/miR-223-3p/NLRP3 Pathway and Offers Neuroprotection in a Transgenic Mouse Model of Alzheimer’s Disease

Alkaloids in Uncaria rhynchophylla improves AD pathology by restraining CD4+ T cell-mediated neuroinflammation via inhibition of glycolysis in APP/PS1 mice

Exploring the therapeutic potential of Nelumbo nucifera leaf extract against amyloid-beta-induced toxicity in the Caenorhabditis elegans model of Alzheimer's disease

Protective Effect of Notoginsenoside R1 on an APP/PS1 Mouse Model of Alzheimer's Disease by Up-Regulating Insulin Degrading Enzyme and Inhibiting A&#946; Accumulation

Neuroprotective, Anti-Amyloidogenic and Neurotrophic Effects of Apigenin in an Alzheimer’s Disease Mouse Model

Norboldine improves cognitive impairment and pathological features in Alzheimer's disease by activating AMPK/GSK3β/Nrf2 signaling pathway

Erjingwan and Alzheimer's disease: research based on network pharmacology and experimental confirmation

Neuroprotective Effects of Oligosaccharides in Rehmanniae Radix on Transgenic Caenorhabditis elegans Models for Alzheimer's Disease

A medicine and food homology formula prevents cognitive deficits by inhibiting neuroinflammation and oxidative stress via activating AEA-Trpv1-Nrf2 pathway

Aβ1‐42‐related Sodium‐calcium Exchanger Isoform‐3 Downregulation in Models of Alzheimer’s Disease: Therapeutic Significance of Withania Somnifera Roots Extract

Qifu-yin activates the Keap1/Nrf2/ARE signaling and ameliorates synaptic injury and oxidative stress in APP/PS1 mice

The Protective Effects of Ecdysterone on Cognitive Impairment Through Regulating Akt/GSK-3β/Nrf2 Signaling Pathway and Oxidative Stress in Cognitive Mice Model and Aβ-Induced Cell Neurotoxicity